跳至主要内容
临床试验/NCT05878951
NCT05878951
招募中
2 期

A Multicenter Randomized Controlled Trial Examining the Effects of Intra-detrusor Botulinum Toxin at Time of Holmium Laser Enucleation of the Prostate (HoLEP) in Men With Overactive Bladder (OAB) Symptoms

Northwestern University1 个研究点 分布在 1 个国家目标入组 80 人2023年7月13日

概览

阶段
2 期
干预措施
OnabotulinumtoxinA
疾病 / 适应症
Urinary Incontinence
发起方
Northwestern University
入组人数
80
试验地点
1
主要终点
Improve Overactive Bladder Symptoms (OAB) utilizing botox injections into the bladder.
状态
招募中
最后更新
3个月前

概览

简要总结

The objective of our multi-center randomized single-blind study is to examine the safety and effect of intra-detrusor OnabotulinumtoxinA injections at the time of holium laser enucleation of the prostate (HoLEP) in men with overactive bladder symptoms with and without urge incontinence.

详细描述

Patients with significant preoperative urgency and/or urge urinary incontinence (UUI) along with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) may require post-HoLEP anticholinergic, B-3 agonist, or intravesical OnabotulinumtoxinA administration. This injection is a guideline recommended for treatment in patients with severe irritative LUTS (urgency, UUI) and overactive bladder.

注册库
clinicaltrials.gov
开始日期
2023年7月13日
结束日期
2026年8月24日
最后更新
3个月前
研究类型
Interventional
研究设计
Parallel
性别
Male

研究者

责任方
Principal Investigator
主要研究者

Amy Krambeck

Professor of Urology

Northwestern University

入排标准

入选标准

  • Males 18 -89 undergoing HoLEP
  • Component of OAB symptoms including frequency, nocturia, urgency, and/or urge related incontinence
  • Willing to sign the Informed Consent Form
  • Able to read, understand, and complete patient questionnaires.

排除标准

  • Allergy or hypersensitivity to OnabotulinumtoxinA injections
  • Patients having a concurrent ureteroscopy +/- laser lithotripsy, percutaneous nephrolithotomy, or non-urologic surgery at the time of their HoLEP
  • Anticipated need for perineal urethrostomy at the time of HoLEP
  • Prior pelvic radiation or patients with a history of bladder cancer with or without BCG therapy
  • Patients who lack decisional capacity
  • Active urinary tract infection

研究组 & 干预措施

Intra-detrusor OnabotulinumtoxinA Injection

Injection of intra-detrusor OnabotulinumtoxinA into the bladder will be performed.

干预措施: OnabotulinumtoxinA

结局指标

主要结局

Improve Overactive Bladder Symptoms (OAB) utilizing botox injections into the bladder.

时间窗: 12 months

Examine the safety and effect of intra-detrusor botulinum toxin injections at the time of helium laser enucleation of the prostate (HoLEP) in men with overactive bladder symptoms with and without urge incontinence.

次要结局

  • Difference in safety/ adverse effects(90 days)
  • Difference in patient REDCap surveys (gross hematuria dysuria, incontinence)(6 months)
  • Difference in efficacy endpoints (3-month clinic/telephone follow-up)(3 months)

研究点 (1)

Loading locations...

相似试验